Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

Recruiting now

Conditions studied: Lung Cancer

In brief

Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.

Key facts

Study ID

NCT06376097

Run by

AstraZeneca

People needed

1000

Starts

2023-04-19

Expected to finish

2026-11-29

Last updated by the study team

2026-08-03

Who can join

Age: 45 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age between 45 and 74 years old; Smoker with a smoking history of at least 30 pack-years or former smoker who has quit smoking for less than 15 years; Never having participated in a lung cancer screening program ; Signing of the free and informed consent form.

You may not qualify if…

• Patients with chronic diseases (cardiovascular, pulmonary, hepatic, renal or metabolic) at an advanced stage that limit life expectancy or make it impossible to perform a curative surgical procedure; Patients being treated for tuberculosis or other granulomatous diseases; Patients diagnosed with previous neoplasm(s) that could develop lung metastases; Pregnant women; Patients who, for some reason, are unable to undergo low-dose chest computed tomography; Patients previously submitted to thoracic radiotherapy.

Where it is running

• Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB) — Botucatu, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.